[Congressional Record Volume 169, Number 78 (Tuesday, May 9, 2023)]
[House]
[Page H2173]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

           By Mr. RASKIN:
       H.R. 3160.
       Congress has the power to enact this legislation pursuant 
     to the following:
       Article I, Section 8, clause 3.
       The single subject of this legislation is:
       Transparency of pharmaceutical research costs.